Diabetic foot ulcer
Successful diabetic foot ulcer treatment using dressings with Safetac
Using dressings with Safetac® in the management of diabetic foot ulcers offers many benefits. Using a number of different dressings with Safetac, these were evaluated in a series of case studies of seven patients with diabetic foot ulcers. Mepilex® Lite, Mepilex® Heel, Mepilex®, Mepilex® Border Lite, Mepitel®, Mepilex® Transfer and Mepilex® Ag were selected according to the different treatment requirements of each wound. In each case the dressings with Safetac were found to overcome the clinical challenges of these difficult wounds and assisted in the wound healing1.
In a non-comparative, observational study evaluating the efficacy and safety of Mepilex Ag in the management of diabetic foot ulcers and the post-operative treatment of diabetic foot associated osteomyelitis, the silver containing dressing was found to be easy to use, malleable, adaptable, and suitable for applying anywhere on the foot. In some cases, Mepilex Ag aided with the pressure off-loading. A favourable healing response was reported for 10/12 wounds (i.e. mean healing time of 57.4 days).
No adverse events were reported. The authors discuss the importance of selecting a dressing as an adjuvant to the treatment of infection that maintains a moist wound environment, allows control of exudate to avoid maceration of the peri-wound region, allows the exchange of gases, isolates the wound, provides comfort for the patient, minimises pain, can be easily removed in order not to damage granulation tissue and peri-lesional skin, and is cost-effective. Based on their accumulated experience, the authors state that Mepilex Ag meets all of these requirements2.